Baxter

Oneview Healthcare and Baxter Announce Connected Care Collaboration During Meeting with Enterprise Ireland

Retrieved on: 
Tuesday, October 17, 2023
Hardware, Telemedicine, Virtual Medicine, Data Management, Consumer Electronics, Technology, Other Policy Issues, Audio, Video, Practice Management, Apps, Applications, General Health, Hospitals, Public Policy, Government, Software, Nursing, Health, Baxter International, Partnership, Nursing care plan, Multimedia, Hospital, Midwestern United States, Health care, AUC, Employment, Caregiver, Baxter, Education, Enterprise, CXP, Growth, Oneview, Patient, Enterprise Ireland

Oneview Healthcare (Oneview), a leading provider of patient experience solutions, and Baxter International Inc. (Baxter), a global medtech leader, are pleased to announce the official launch of their strategic relationship in the United States.

Key Points: 
  • Oneview Healthcare (Oneview), a leading provider of patient experience solutions, and Baxter International Inc. (Baxter), a global medtech leader, are pleased to announce the official launch of their strategic relationship in the United States.
  • View the full release here: https://www.businesswire.com/news/home/20231017296352/en/
    Oneview Healthcare, Enterprise Ireland, and Baxter at the Baxter Headquarters.
  • Baxter will now offer Oneview’s Care Experience Platform (CXP) to their hospital customers across the United States.
  • During the meeting with the Irish government Minister for Enterprise, Trade, and Employment, Simon Coveney, representatives from both Oneview Healthcare and Baxter expressed their enthusiasm for the collaboration and outlined their shared vision for the future of healthcare.

BAXTER ALERT: Bragar Eagel & Squire, P.C. is Investigating Baxter International, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, October 12, 2023
Class Action Lawsuit, Professional Services, Legal, Jeanne Eagels, News, Baxter International, NYSE, Telephone, Face, P.C, Cryptocurrency, Baxter

Our investigation concerns whether the board of directors of Baxter have breached their fiduciary duties to the company.

Key Points: 
  • Our investigation concerns whether the board of directors of Baxter have breached their fiduciary duties to the company.
  • Following this news, Baxter shares fell $5.23 per share, or 11.5%, from $45.37 to close at $40.14 per share on February 9, 2023.
  • Over the course of the Class Period, Baxter’s stock price declined by nearly 50%, eliminating billions of dollars in market capitalization.
  • There is no cost or obligation to you.

Baxter Appoints Joel Grade Chief Financial Officer

Retrieved on: 
Tuesday, October 3, 2023
Biotechnology, Health, Finance, Other Health, Accounting, Pharmaceutical, Surgery, Professional Services, Practice Management, Medical Devices, General Health, Hospitals, Health Technology, Medical Supplies, Specialization, University, Marketing, Baxter, Sysco, MBA, History, University of Wisconsin–Madison School of Education, Baxter International, Organization, In re Caremark International Inc. Derivative Litigation, Patient, Ernst, Ernst & Young, CFO, Growth, NYSE, Northwestern University Master of Product Design and Development Management, Kellogg School of Management, Management

Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced it has appointed Joel Grade as executive vice president and chief financial officer (CFO), reporting to Baxter chairman, president and CEO, José (Joe) E. Almeida, effective Oct. 18, 2023.

Key Points: 
  • Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced it has appointed Joel Grade as executive vice president and chief financial officer (CFO), reporting to Baxter chairman, president and CEO, José (Joe) E. Almeida, effective Oct. 18, 2023.
  • “Joel is a seasoned global financial executive with decades of deep operational and broad business experience as well as a proven record of results-driven impact,” said Mr. Almeida.
  • Mr. Grade brings deep experience from various financial, commercial and executive leadership roles.
  • “I’m very excited to join Baxter, an industry leader with a rich history, compelling future, patient-centric mission, and best-in-class talent,” said Mr. Grade.

Spectral Medical Provides Tigris Trial Update

Retrieved on: 
Tuesday, October 3, 2023
Sepsis, Septic shock, Baxter, TSX, Mortality, Baxter International, Patient, PMX, Spectral, Pharmaceutical industry

TORONTO, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today provided an update on the progress of its Tigris trial including patient enrollment and new trial site additions to further accelerate patient enrollment.

Key Points: 
  • TORONTO, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today provided an update on the progress of its Tigris trial including patient enrollment and new trial site additions to further accelerate patient enrollment.
  • As of October 2, 2023, the Company had 74 patients enrolled in its Phase 3 Tigris clinical trial with crude mortality data continuing to exceed expectations.
  • To further accelerate patient enrollment, reach the interim milestone of 90 enrolled patients and subsequently complete the Tigris trial, Spectral is on track to add seven new vetted trial sites in the United States around the end of November 2023.
  • “We are taking decisive action to maintain and even increase momentum in patient enrollment with a view to enrolling our interim count of 90 patients, which is expected to play as a major catalyst for the Company,” said Chris Seto, Chief Executive Officer of Spectral Medical.

Global Blood Transfusion Set Market Expected to Rebound with 3.0% CAGR, Reaching $591 Million by 2030 - ResearchAndMarkets.com

Retrieved on: 
Friday, September 29, 2023
Health, Other Health, Male, IV, Prevalence, ICU Medical, Pump, Baxter, Cancer, Luer, Domination, Research, BD (company), Blood transfusion, Chronic, BD, Medical device, Pharmaceutical industry, Alaris

In 2023, the global blood transfusion set market reported a total value of $480.1 million, experiencing a modest decline of 3.5% from the $464.1 million recorded in 2022.

Key Points: 
  • In 2023, the global blood transfusion set market reported a total value of $480.1 million, experiencing a modest decline of 3.5% from the $464.1 million recorded in 2022.
  • Currently, market leaders in the global blood transfusion set market include Becton Dickinson (BD), Baxter, and ICU Medical.
  • Rebound Expected: The global blood transfusion set market is projected to rebound with a CAGR of 3.0%, reaching a valuation of $591 million, following a 3.5% decline in 2023.
  • Dominant Players: Key players such as Becton Dickinson (BD), Baxter, and ICU Medical currently dominate the global blood transfusion set market.

Trinity Life Sciences Appoints Advisory Board

Retrieved on: 
Wednesday, September 20, 2023
Software, Other Health, General Health, Pharmaceutical, Data Management, Technology, Artificial Intelligence, Health Technology, Science, Biotechnology, Other Technology, Health, Other Science, Amgen, GSK plc, Nursing care plan, Accenture, IQVIA, Trinity, Baxter, Market access, Innovation, Ortho Clinical Diagnostics, Bristol Myers Squibb, Central Waqf Council, WW, Neptune Wellness Solutions, Transfusion medicine, Johnson & Johnson, BMS, Digital, Social media, Financial adviser, Management, Pharmaceutical industry, Pharma, Automotive industry

Trinity Life Sciences , a leader in global life sciences commercialization solutions, has announced its Board of Advisors, a group of independent, expert advisors that will help advance Trinity’s mission .

Key Points: 
  • Trinity Life Sciences , a leader in global life sciences commercialization solutions, has announced its Board of Advisors, a group of independent, expert advisors that will help advance Trinity’s mission .
  • Trinity is the fourth company Mr. Corcoran has founded or co-founded, after successful endeavors in social media, medical devices, and pharma- and biotech-focused software development.
  • “My team and I are thrilled to be working with the foremost innovative thinkers in our industry,” said Leslie Orne , President & CEO of Trinity Life Sciences.
  • “Their combined expertise is second to none and will serve as guiding voices as Trinity continues to transform the way life sciences companies think about and execute on their goals.”

MCINTOSH GROUP ANNOUNCES NEW HOUSE OF SOUND EXPERIENCE CENTER

Retrieved on: 
Thursday, September 21, 2023
McIntosh Group, Music, HRS, Baxter, Foot, Sonus Faber, Jeep Grand Wagoneer, Pro-Ject, Home theater in a box, Home, USM, Bubble Houses (Hobe Sound, Florida), Abyss, Longevity, House, Cassette tape, Television, AudioQuest, Sound, Sony, Rotel

NEW YORK, Sept. 21, 2023 /PRNewswire/ -- McIntosh Group is excited to announce the launch of its one-of-a-kind experience center— House of Sound, a thoughtfully curated multi-sensory townhouse that highlights the group's brands and premium audio innovations.

Key Points: 
  • NEW YORK, Sept. 21, 2023 /PRNewswire/ -- McIntosh Group is excited to announce the launch of its one-of-a-kind experience center— House of Sound, a thoughtfully curated multi-sensory townhouse that highlights the group's brands and premium audio innovations.
  • McIntosh Group is reimagining how consumers experience audio in the modern era.
  • Following in the footsteps of its first iteration, the World of McIntosh townhouse, the House of Sound serves as an experiential showroom featuring the latest designs in cutting-edge audio technology across the McIntosh Group portfolio, which includes McIntosh, Sonus faber, Rotel, Pro-Ject Audio Systems, and Sumiko Phono.
  • "We created the House of Sound to bring to life McIntosh Group's core design principles across high-end sound, versatility, and longevity for not only our tried-and-true brand fans but also as a way to convert music and film lovers into audio-enthusiasts," said Daniel Pidgeon, CEO of McIntosh Group.

Jack and Jill of America, Incorporated On The Hill Legislative Summit set for September 22-25, 2023

Retrieved on: 
Tuesday, September 19, 2023
Mitsubishi Electric America Foundation, University, 16th Street Baptist Church, AARP, White Bird Hill Summit, Washington, D.C., Baxter, University of the District of Columbia, Ford, Washington metropolitan area, Black, UDC, Senator, OTH, Capitol, Boy, Mental health, African Americans, Nursing, Prudential, Unilever

WASHINGTON, Sept. 19, 2023 /PRNewswire/ -- On The Hill Summit (OTH), Jack and Jill of America, Inc.'s flagship legislative event, will be held September 22 through September 25 at the Grand Hyatt in Washington, D.C.

Key Points: 
  • WASHINGTON, Sept. 19, 2023 /PRNewswire/ -- On The Hill Summit (OTH), Jack and Jill of America, Inc.'s flagship legislative event, will be held September 22 through September 25 at the Grand Hyatt in Washington, D.C.
  • 2023 On The Hill Legislative Summit Priorities:
    The OTH 2023 event schedule includes a Black Business Vendors Summit, National President's welcome reception and awards night, "Power of Advocacy" speaker series, mental health pop-up, and a day on the Capitol for teens to engage with Congressional Representatives and Senators.
  • Sponsors for Jack and Jill of America, Inc.'s 2023 On The Hill Legislative Summit include Unilever, Ford, AARP, Baxter, Prudential, and Jack and Jill of America Foundation.
  • Learn about Jack and Jill of America, Inc. by visiting jackandjillinc.org and @jackandjillinc on Facebook, Instagram, Twitter, TikTok, or LinkedIn: Jack and Jill of America, Inc.

Baxter Planning's predictive Service Supply Chain platform chosen by Roche Diagnostics Corporation for Service Supply Chain Optimization

Retrieved on: 
Tuesday, September 19, 2023
Civil Service Supply Association, Baxter, Roche, Spare Parts, Retail

AUSTIN, Texas, Sept. 19, 2023 /PRNewswire/ -- Baxter Planning, the leading provider of Service Parts Management technology, today announced that Roche Diagnostics Corporation, the North American headquarters for Roche Diagnostics, selected Baxter Planning as a service optimization partner. Roche will be leveraging Baxter Planning's Service Parts Management Platform, BaxterPredict, to maximize parts availability.

Key Points: 
  • AUSTIN, Texas, Sept. 19, 2023 /PRNewswire/ -- Baxter Planning, the leading provider of Service Parts Management technology, today announced that Roche Diagnostics Corporation, the North American headquarters for Roche Diagnostics, selected Baxter Planning as a service optimization partner.
  • Roche will be leveraging Baxter Planning's Service Parts Management Platform, BaxterPredict, to maximize parts availability.
  • The Baxter Planning Predictive Service Supply Chain Platform solution connects disparate workflows and teams with AI-enabled predictive insights that drive significant productivity gains, cost savings, and customer satisfaction.
  • This new, predictive approach to inventory planning, demand forecasting, product-lifecycle planning, operations-workflow monitoring, reverse logistics, and customer-escalation management unlocks significant new value for Service Supply Chain organizations.

DEADLINE ALERT for BAX, RAIN, PTRA, and SE: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Retrieved on: 
Monday, September 11, 2023
Proterra, Face, Baxter, Law, MANTRA, Sea Ltd, Complaint, Suite, Investment, Defendant, Growth, FDA, Security (finance)

LOS ANGELES, Sept. 11, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.

Key Points: 
  • LOS ANGELES, Sept. 11, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
  • Investors suffering losses on their investments are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights in these class actions at 310-914-5007 or by email to [email protected] .
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
  • The Law Offices of Frank R. Cruz, Los Angeles